Trials / Completed
CompletedNCT03880253
Multiple Ascending Dose Study of CTP-692 in Healthy Volunteers
A Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetic Profile of CTP-692 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Concert Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study will assess in healthy male and female subjects the safety and pharmacokinetic (PK) profiles of 3 dose levels of CTP-692 following 7 days of dosing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CTP-692 | Placebo or CTP-692 |
Timeline
- Start date
- 2019-04-10
- Primary completion
- 2019-05-16
- Completion
- 2019-05-16
- First posted
- 2019-03-19
- Last updated
- 2019-06-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03880253. Inclusion in this directory is not an endorsement.